| Literature DB >> 35125541 |
Flavia Riccardo1, Giorgio Guzzetta2, Alberto Mateo Urdiales1, Martina Del Manso1, Xanthi D Andrianou1, Antonino Bella1, Patrizio Pezzotti1, Simona Carbone3, Tiziana De Vito3, Francesco Maraglino3, Vittorio Demicheli4, Claudio Dario5, Enrico Coscioni6, Giovanni Rezza3, Andrea Urbani3, Stefano Merler2, Silvio Brusaferro1.
Abstract
PROBLEM: After Italy's first national restriction measures in 2020, a robust approach was needed to monitor the emerging epidemic of coronavirus disease 2019 (COVID-19) at subnational level and provide data to inform the strengthening or easing of epidemic control measures. APPROACH: We adapted the European Centre for Disease Prevention and Control rapid risk assessment tool by including quantitative and qualitative indicators from existing national surveillance systems. We defined COVID-19 risk as a combination of the probability of uncontrolled transmission of severe acute respiratory syndrome coronavirus 2 and of an unsustainable impact of COVID-19 cases on hospital services, adjusted in relation to the health system's resilience. The monitoring system was implemented with no additional cost in May 2020. LOCALEntities:
Mesh:
Year: 2021 PMID: 35125541 PMCID: PMC8795855 DOI: 10.2471/BLT.21.286317
Source DB: PubMed Journal: Bull World Health Organ ISSN: 0042-9686 Impact factor: 9.408
Indicators used in the weekly COVID-19 epidemiological monitoring in regions and autonomous provinces, Italy, 2020–2021
| Indicator set | Indicator | Threshold | Alert |
|---|---|---|---|
|
| |||
| Quality of data collected at the national level | 1.1. Percentage of symptomatic cases with date of symptom onset reported | ≥ 60% of cases with increasing trendsa | < 60% of cases with increasing trends |
| 1.2. Percentage of cases admitted to hospital (non-intensive care ward) with a date of admission or transfer reported | |||
| 1.3. Percentage of cases admitted to hospital (intensive care unit) with a date of admission or transfer reported | |||
| 1.4. Percentage of notified cases with the municipality of residence reported | |||
| Ability to test all cases in a timely manner | 2.1. Percentage of swabs positive for SARS-CoV-2 infection per month, excluding swabs from screening and re-testing; overall and by setting (local, non-hospital, hospital emergency department, other) | Decreasing percentage of positive swabs in hospital settings or emergency departments. | Increasing percentage of positive swabs in hospital settings or emergency departments. |
| 2.2. Time between date of symptom onset and date of diagnosis of cases | Weekly median gap ≤ 5 days | Weekly median gap > 5 days | |
|
| |||
| Adequacy of staff resources for contact tracing, isolation and quarantine | 2.4. Number of staff dedicated to contact tracing in each local health unit | (SARS-CoV-2) 1 professional staff member per 10 000 population | < 1 professional staff member per 10 000 population |
| 2.5. Number of staff dedicated in each unit to the activities for the collection and dispatch of clinical samples to the reference laboratories and monitoring of cases and close contacts placed in quarantine and in isolation, respectively | |||
| 2.6. Number of confirmed cases in the region for which an epidemiological investigation has been carried out, with the search for close and total contacts of new confirmed cases | Increasing number of investigated cases (final target 100%) | Decreasing number of investigated cases (and lower than 90%) | |
|
| |||
| Transmission stability | 3.1. Number of cases diagnosed in the last 14 days, reported to the health ministry | Weekly number of diagnosed cases stable or decreasing | Increasing number of diagnosed cases in last 5 days |
| 3.2. Value of transmissibility parameter based on data from the integrated central surveillance system. Two indicators are used, one based on date of symptom onset and one on date of hospitalizationb | Regional net reproduction number (Rt) ≤ 1 in all regions and autonomous provincesc | Rt > 1 or not assessed | |
| 3.4. Number of cases per date of diagnosis and date of symptom onset reported to the integrated central surveillance system per day | Weekly number of reported cases stable or decreasing | Increasing number of diagnosed cases in last 5 days | |
| 3.5. Number of new SARS-CoV-2 clusters, defined as two or more epidemiologically linked cases or an unexpected increase in the number of cases at a defined time and place | No increase in the number of active clusters in the region (that is, clusters with cases still in isolation or quarantine, or new cases reported during the week) | Increasing number of active clusters in the region (that is, clusters with cases still in isolation or quarantine, or new cases reported during the week) | |
| 3.6. Number of new cases not associated with known chains of transmission | No explicit thresholds (qualitative assessment). If new outbreaks occur, the indicator can monitor the quality of contact tracing. Otherwise, the indicator could represent low transmission in which only sporadic cases are observed (considering undetected circulation in people with few symptoms) | In the presence of outbreaks, the indicator requires an unplanned risk assessment defining whether there is sustained and widespread transmission that requires an escalation of epidemic control measures | |
| Pressure on health-care system | 3.8. Bed occupancy rate (percentage of available active hospital beds occupied by COVID-19 patients) in intensive care units for COVID-19 patients | Bed occupancy, intensive care ≤ 30% | Bed occupancy, intensive care > 30% |
| 3.9. Bed occupancy rate (percentage of available active hospital beds occupied by COVID-19 patients) in non-intensive care wards for COVID-19 patients | Bed occupancy, non-intensive care ≤ 40% | Bed occupancy, non-intensive care > 40% | |
COVID-19: coronavirus disease 2019; SARS-CoV-2: severe acute respiratory syndrome coronavirus 2.
a A value of at least 50% of cases with increasing trends was considered acceptable between 4 May and 25 May 2020.
b We have previously described the details of the calculations.
c Net reproduction number is the transmissibility potential of the disease at a given time t of the disease.
Notes: Cases refer to people with a laboratory confirmed diagnosis of SARS-CoV-2 infection reported to the national surveillance system. Translated with minor adaptations from the Decree of the Italian health ministry, 30 April 2020. The table only includes the non-optional indicators reported in the original ministerial decree as the other indicators were not relevant either because they were never compiled or because they just had a complementary role to the non-optional indicators here reported.
Fig. 1Epidemic curve and weekly risk assessment of the COVID-19 epidemic by region and autonomous province, Italy, 4 May 2020 to 27 September 2021